Published in Medical Letter on the CDC and FDA, November 18th, 2007
In Spain, Laboratorios Davur, as well as two other Bentley subsidiaries, Laboratorios Rimafar and Laboratorios Belmac, received approval for alendronate weekly. Alendronate is used in the treatment of osteoporosis and bone loss, and is the generic version of Fosamax(R), which is currently marketed by Merck & Company, Inc. According to IMS Health, Inc., annual brand sales...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA